Tenaya Therapeutics, Inc. (TNYA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 108.84M |
| Enterprise Value | 19.12M |
| P/E Ratio | -1.32 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 113.34 |
| Price/Book Ratio | 2.19 |
| Enterprise/Revenue | 57.81 |
| Enterprise/EBITDA | -0.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -77.24 |
| Operating Margin | -79.3 |
| Return On Assets | -1.1 |
| Return On Equity | -1.08 |
| Revenue | 0 |
| Revenue/Share | 0.01 |
| Gross Profit | -8.44M |
| EBITDA | -82.16M |
| Net Income | -90.6M |
| Diluted EPS | -0.59 |
| Total Cash | 78.08M |
| Total Cash/Share | 0.36 |
| Total Debt | 3.95M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.52 |
| Book Value Per Share | 0.32 |
| 52-Week Change | -38.29 |
| 52-Week High | 2.35 |
| 52-Week Low | 0.53 |
| Moving Average 50 Days | 0.76 |
| Moving Average 200 Days | 0.83 |
| Average Volume | 2.55M |
| Shares Outstanding | 217M |
| % Held by Institutions | 35.5 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |